Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.
PrivateLast Round
Series A
Jun 1, 2022
Total Funding Raised
$15.34M
Company Overview
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series A round in June 2022.
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. is a biotechnology company that focuses on the research and development of novel small molecule drugs for the treatment of immunology and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Comparables
Compare Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adiso Therapeutics | 85% | |
| AQILION AB (publ) | 81% | |
| Landos Biopharma | 77% |
For institutional investors. Book with your work email.
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2022 | ||||
| Angel | Mar 1, 2021 |
For institutional investors. Book with your work email.
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series A |
| Kaitai Capital | Angel |
| Anlong Fund | Angel |
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. a public or private company?
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.?
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. worth (valuation)?
Valuation information for Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. is not publicly available.
Can I buy Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. stock?
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.'s last funding round?
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.'s most recent funding round was Series A on June 1, 2022.
Who are the main investors in Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.?
Key investors in Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. include HighLight Capital, Kaitai Capital, Anlong Fund.
Will Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Allianthera (Suzhou) Biopharmaceuticals Co., Ltd..
How can I track Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.'s shares on secondary markets.